Press releases
Read more:
Categories
2019
2019-01-30 12:02
Nanologica and AstraZeneca joint evaluation project
Nanologica and AstraZeneca have entered into an agreement for the evaluation of Nanologica’s pending patented technology, applied to AstraZeneca...
2018
2018-11-08 11:40
Nanologica expands its technology platform
One of Nanologica’s patent applications has today become public. Through the patent, Nanologica is seeking to strengthen and expand its technology...
2018-10-03 11:36
Exclusivity agreement for the Chinese market
Nanologica AB (publ) has today entered into a five-year distribution agreement with Yunbo Technology (Beijing) Co. for the Chinese market. The agreement...
2018-07-03 11:24
Nanologica one step closer to milestone payment
Vicore Pharma AB (publ) will decide on an acquisition of INIM Pharma AB, where Nanologica AB is a minor shareholder, in an Extraordinary General Meeting...
2018-05-16 10:08
Nanologica signs a Chinese agreement within food control
Nanologica has signed a three-year supply agreement with Chinese SinoUnison who focuses on analytical services within food control. Nanologica will supply...
2018-05-16 10:04
Nanologica licences technology to HealthCap company
Nanologica licenses part of its technology platform to INIM Pharma AB, a company set up by HealthCap. The new company is focused on certain therapeutic...
2018-03-12 08:32
Vd Andreas Bhagwani presenterar nyemissionen
Länk till presentationen
2017
2017-11-13 22:50
Andreas Bhagwanis presentation at Swedish Shareholders Associations ”Stora Aktiedagen” in Stockholm
https://www.youtube.com/watch?v=pXhda3qlFWQ
2016
2016-08-31 10:45
Nanologica and Teva enter into a Feasibility Study Agreement
Nanologica has today announced that it enters into a Feasibility Study Agreement with Teva. Under the agreement, Nanologica will develop a customized drug...
2016-08-24 08:30
Nanologica enters into research collaboration with GSK
”We are excited about the collaboration with GSK. This is an early, but interesting project with the possibility to unlock new approaches to personalized...